# DIEBOLD NIXDORF, Inc: Form 10-Q for the period ended Jun 30, 2026

- Company: [DIEBOLD NIXDORF, Inc](/companies/dbd.md) (CIK 28823)
- Form: 10-Q
- Filed: 2026-07-29
- Accepted by EDGAR: Jul 29, 2026, 16:06 ET
- Period: 2026-06-30
- Accession: 0000028823-26-000033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/28823/000002882326000033/dbd-20260630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/28823/000002882326000033/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-04-01 to 2026-06-30 | $930.8m | us-gaap:Revenues |
| Revenue | 6 months, 2026-01-01 to 2026-06-30 | $1.82bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2026-04-01 to 2026-06-30 | $691.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2026-01-01 to 2026-06-30 | $1.37bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2026-04-01 to 2026-06-30 | $239.6m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2026-01-01 to 2026-06-30 | $452.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2026-04-01 to 2026-06-30 | $20.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2026-01-01 to 2026-06-30 | $42.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2026-04-01 to 2026-06-30 | $162.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2026-01-01 to 2026-06-30 | $319.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2026-04-01 to 2026-06-30 | $57.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2026-01-01 to 2026-06-30 | $90.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2026-04-01 to 2026-06-30 | $24.1m | us-gaap:InterestExpenseNonoperating |
| Interest expense | 6 months, 2026-01-01 to 2026-06-30 | $47.4m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2026-04-01 to 2026-06-30 | $19.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2026-01-01 to 2026-06-30 | $25.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-04-01 to 2026-06-30 | $15.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2026-01-01 to 2026-06-30 | $20.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-04-01 to 2026-06-30 | $0.44 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2026-01-01 to 2026-06-30 | $0.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-04-01 to 2026-06-30 | $0.45 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2026-01-01 to 2026-06-30 | $0.59 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-04-01 to 2026-06-30 | 35,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2026-01-01 to 2026-06-30 | 35,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2026-01-01 to 2026-06-30 | $18.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 6 months, 2026-01-01 to 2026-06-30 | $121.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2026-06-30 | $1.71bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-06-30 | $3.74bn | us-gaap:Assets |
| Current liabilities | at 2026-06-30 | $1.35bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-06-30 | $2.76bn | us-gaap:Liabilities |
| Long-term debt | at 2026-06-30 | $942.9m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2026-06-30 | $969.2m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/28823/000002882326000033/dbd-20260630.htm

Filed Jul 29, 2026.
Source: SEC EDGAR, the filing index for accession 0000028823-26-000033. Last ingested by Listed: Oct 28, 2026, 07:18 ET. No prices; not investment advice.